F. Fiorentino, B. Canali, P. Morelli, and F. Demma, “Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy”, AboutOpen, vol. 10, no. 1, pp. 6–12, Jan. 2023.